Immunorestoration of Immunodeficiency by Biological Response Modifiers
It is well known that there are many mediators which are important in the generation and execution of immune responses. These mediators, when generated by lymphoid cells or when acting on lymphoid targets, have been termed lymphokines and those acting on non-lymphoid targets have been named cytokines. The combination term “lymphokine/cytokine” has been used to refer to the general class of soluble substances mediating biological responses in cell-cell interactions. These substances are distinct from, although similar to, hormones which are generally secreted by cells within the endocrine system acting on a remote target.
KeywordsNatural Killer Cell Chronic Lymphocytic Leukemia Alpha Interferon Roswell Park Memorial Institute Biological Response Modifier
Unable to display preview. Download preview PDF.
- 1.R. K. Oldham, Biologicals and biological response modifiers: fourth modality of cancer treatment, Cancer Treat. Rpt. 68 (1): 221 (1984).Google Scholar
- 2.B. H. Waksman, Overview: biology of the lymphokines, in: “Biology of Lymphokines,” eds., Academic Press (1979).Google Scholar
- 4.R. K. Oldham, Biological response modifiers program, Biol. Resp. Modif. 1: 81 (1982).Google Scholar
- 5.I. J. Fidler, M. Berendt, and R. K. Oldham, The rationale for design of screening assays for the assessment of biological response modifiers for cancer treatment, J. Biol. Resp. Modif. 1: 15 (1982).Google Scholar
- 6.J. E. Talmadge, R. K. Oldham, and I. J. Fidler, Practical considerations for the establishment of a screening procedure for the assessment of biological response modifiers, J. Biol. Resp. Modif. 3: 88 (1984).Google Scholar
- 11.P. A. Bunn, Jr., K. A. Foon, D. C. Idhe, et al., Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas, Annals Int. Med. 101 (4): 484 (1984).Google Scholar
- 14.R. K. Oldham, K. A. Foon, A. C. Morgan, et al., Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration, Clin. Oncol. 2 (11): 1235 (1984).Google Scholar
- 19.S. L. Giardina, R. W. Schroff, C. S. Woodhouse, et al., Detection of two distinct malignant B-cell clones in a single patient using anti-idiotype monoclonal antibodies and immunoglobulin in gene rearrangement, (submitted, 1984 ).Google Scholar
- 20.R. K. Oldham and R. V. Smalley, Immunotherapy: the old and the new, J. Biol. Resp. Modif. 2: 1 (1983).Google Scholar